Product Information
NORTRIPTYLINE HCL 50 MG CAP is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.2022 per EA under NDC 00093081205. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Mar 27, 1995. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093081205
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
NORTRIPTYLINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA074132FDA Approved
3/27/1995
TE Code
AB
On Market Since
4/5/1995
Pharmacological Classes
Price Statistics
The NADAC for NORTRIPTYLINE HCL 50 MG CAP has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 29.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2022 per EA |
|---|---|
| All-time high | $0.2316 (Dec 10, 2025) |
| All-time low | $0.0929 (Apr 17, 2024) |
| 52-week high | $0.2316 |
| 52-week low | $0.2022 |
| Median price | $0.1455 |
| Average price | $0.1513 |
| Largest weekly change | +31.7% (Oct 23, 2024) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of NORTRIPTYLINE HCL 50 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for NORTRIPTYLINE HCL 50 MG CAP, manufactured by Teva Pharmaceuticals USA Inc., is $0.2022 per EA (NDC 00093081205), effective Aug 19, 2026.
How has the price of NORTRIPTYLINE HCL 50 MG CAP changed over time?
Over the history we have for it, the NADAC for NORTRIPTYLINE HCL 50 MG CAP has risen 29.2%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NORTRIPTYLINE HCL 50 MG CAP?
Since Nov 28, 2013, the NADAC for NORTRIPTYLINE HCL 50 MG CAP has ranged from a low of $0.0929 (Apr 17, 2024) to a high of $0.2316 (Dec 10, 2025), with a median of $0.1455 per EA.
Are there cheaper alternatives to NORTRIPTYLINE HCL 50 MG CAP?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as NORTRIPTYLINE HCL 50 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures NORTRIPTYLINE HCL 50 MG CAP?
NORTRIPTYLINE HCL 50 MG CAP (NDC 00093081205) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.